<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly!

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Target to Lead Selection for ADCs and Biologics

Journey through the drug discovery pipeline from target discovery to in vivo pharmacology. Take advantage of the Largest biobank of patient-derived models, Model development capabilities, Cell-based assays for Screening ADCs, and advanced downstream analysis.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Preclinical Consulting Services

Learn more about how our consulting services can help to support your journey to the clinic.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types

Enhanced Sarcoma PDX Models for Predictive Preclinical Evaluation

Patient-derived xenograft (PDX) models provide a predictive preclinical model for the evaluation of an agents efficacy prior to entering the clinic. The Crown Bioscience collection contains many sarcoma PDX models of both North American and Asian decent for a true representation of the variability found in the patient population. More

PDX offer the most translational preclinical model for efficacy screening in cancer drug development. Derived directly from patient tumors and never adapted to grow in vitro, PDX models reflect the heterogeneity and diversity of the human patient population. PDX give you an accurate, predictive model of how your treatment will perform, well before entering into expensive clinical trials. Crown Bioscience's HuPrime® PDX models are well characterized for pathology, growth characteristics, and are also genetically/genomically annotated for gene expression, gene copy number, mutations, and fusions.

MODEL NUMBER CANCER TYPE CANCER SUBTYPE DESCRIPTION # per page
SA0271 Sarcoma Spindle cell carcinoma Alveolar soft part sarcoma. IHC results: CD99(+), CD(-), HMB45(+/-), PAS(+/-), CK(+/-), Des(-), NSE(+/-), S-100(-). CLICK TO VIEW
SA0319 Sarcoma Spindle cell carcinoma Myxofibrosarcoma of abdominal wall. CLICK TO VIEW
SA0639 Sarcoma rhabdomyosarcoma Pleomorphic rhabdomyosarcoma, IHC results: Myoglobin(+), Desmin(focus +), SMA(focus +), Myogenine(-), MyoD1(-), CD34(-), CD117(-), S-100(-), PMP-22(+/-, Ki-67(tumor cells 80% +). CLICK TO VIEW
SA0666 Sarcoma Spindle cell carcinoma Fusocellular sarcoma. CLICK TO VIEW
SA10132 Sarcoma Sarcoma Rhabdomyosarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. 30% NECROSIS. TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10139 Sarcoma clear cell sarcoma Recurrent Clear Cell Sarcoma. Pathol comment: ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10145 Sarcoma Sarcoma Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10146 Sarcoma NA Soft Tissue Sarcoma. Pathol comment: ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10151 Sarcoma NA Liposarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10153 Sarcoma Sarcoma Synovial Sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10154 Sarcoma Sarcoma Soft Tissue Sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10157 Sarcoma LEIOMYOSARCOMA Mestastatic leiomyosarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10159 Sarcoma synovial sarcoma Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10160 Sarcoma LEIOMYOSARCOMA Recurrent leiomyosarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10162 Sarcoma synovial sarcoma NA CLICK TO VIEW
SA10164 Sarcoma Sarcoma Leiomyosarcoma/Myxoid Sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10166 Sarcoma Sarcoma Leiomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10171 Sarcoma Soft Tissue Sarcoma Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 70% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10174 Sarcoma RHABDOMYOSARCOMA Rhabdomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10175 Sarcoma Sarcoma Soft Tissue Sarcoma. Mediastinal synovial sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10180 Sarcoma NA Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROX. 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10181 Sarcoma RHABDOMYOSARCOMA Recurrent Rhabdomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10182 Sarcoma LEIOMYOSARCOMA Leiomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10192 Sarcoma Spindle cell carcinoma N/A CLICK TO VIEW
SA10194 Sarcoma Sarcoma Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 100% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10196 Sarcoma NA Sarcoma. Pathol comment: APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. C/W METASTATIC SARCOMA. APPROXIMATELY 5% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10199 Sarcoma NA Recurrent malignant solitary fibrous tumor. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10202 Sarcoma Leiomyosarcoma N/A CLICK TO VIEW
SA10215 Sarcoma NA Sarcoma. CLICK TO VIEW
SA10216 Sarcoma Leiomyosarcoma Leiomyosarcoma CLICK TO VIEW
SA10225 Sarcoma fibrosarcoma Mestastatic pleomorphic high grade sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10232 Sarcoma Ewing's sarcoma Ewing's sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. FOCAL TUMOR NECROSIS. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10233 Sarcoma Ewing's sarcoma Ewing's sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. APPROXIMATELY 90% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10242 Sarcoma Sarcoma Synovial Cell Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA10243 Sarcoma Malignant fibrous histiocytoma Malignant fibrous histiocytoma. Undifferentiated pleomorphic sarcoma, high grade. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10245 Sarcoma Sarcoma Malignant fibrous histiocytoma. C/W RECURRENT/METASTATIC MALIGNANT FIBROUS HISTIOCYTOMA. C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 70% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA10992 Sarcoma NA Desmoplastic Small Round Cell. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13127 Sarcoma Leiomyosarcoma NA CLICK TO VIEW
SA13174 Sarcoma Liposarcoma Soft Tissue Sarcoma. Liposarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13179 Sarcoma Leiomyosarcoma Soft Tissue Sarcoma. Recurrent leiomyosarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. APPROXIMATELY 70% OF TISSUE INVOLVED BY TUMOR IN SECTIONS EXAMINED. TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13187 Sarcoma NA Sarcoma, malignant tumor most C/W rhabdoid tumor. Pathol comment: ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13230 Sarcoma Soft tissue sarcoma NA CLICK TO VIEW
SA13256 Sarcoma NA Retroperitoneal Sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13284 Sarcoma NA Soft Tissue Sarcoma. Metastatic intermediate grade sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13290 Sarcoma Soft Tissue Sarcoma N/A CLICK TO VIEW
SA13298 Sarcoma Leiomyosarcoma Leiomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13302 Sarcoma Soft Tissue Sarcoma N/A CLICK TO VIEW
SA13305 Sarcoma Rhabdomyosarcoma Soft Tissue Sarcoma. Rhabdomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13326 Sarcoma NA Soft Tissue Sarcoma. Sarcoma, HG, with muxoid and chondroid features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13327 Sarcoma fibrosarcoma Soft Tissue Sarcoma. Pathol comment: C/W REFERRING DIAGNOSIS. ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13354 Sarcoma Leiomyosarcoma Soft Tissue Sarcoma. C/W PREVIOUS DIAGNOSED LEIOMYOSARCOMA. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 80% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13375 Sarcoma Sarcoma Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13389 Sarcoma Sarcoma Soft Tissue Sarcoma. Epithelioid neoplasm, c/w myoepithelioma of soft tissues. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA1340 Sarcoma Leiomyosarcoma NA CLICK TO VIEW
SA13404 Sarcoma Sarcoma Soft Tissue Sarcoma. Synovial cell sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13405 Sarcoma NA Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13412 Sarcoma NA Mestastatic mutifocal sarcoma, C/W synovial sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13441 Sarcoma synovial sarcoma Spindle cell sarcoma, high grade. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA13452 Sarcoma NA Myxoid sarcoma, most C/W myxoid leiomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA13455 Sarcoma NA Leiomyosarcoma, high grade. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. 10% NECROSIS. APPROXIMATELY 80% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA13510 Sarcoma Gliosarcoma NA CLICK TO VIEW
SA13542 Sarcoma Ewing's sarcoma Ewing's Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA13543 Sarcoma Ewing's sarcoma Ewing's sarcoma, small round blue cell tumor. Pathol comment: C/W RECURRENT EWING'S SARCOMAC/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16043 Sarcoma NA Soft Tissue Sarcoma. Pulmonary blastoma with rhabdomyosarcomatosis features. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16044 Sarcoma NA Soft Tissue Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16047 Sarcoma NA Soft Tissue Sarcoma, metastatic alveolar soft part sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 90% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16050 Sarcoma Soft Tissue Sarcoma Leiomyosarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 60% OF THE TISSUE INVOLVED MALIGNANT TUMOR IN SECTIONS EXAMINED. 20% NECROTIC. MALIGNANT CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16052 Sarcoma NA Sarcoma. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 100% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. APPROXIMATELY 60% MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREPARATION. CLICK TO VIEW
SA16055 Sarcoma Osteosarcoma Osteosarcoma, recurrent osteosarcoma of the skull. Pathol comment: ENTIRE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA16056 Sarcoma NA Ewing's Sarcoma, extra osseus ewings. Pathol comment: C/W DIAGNOSIS. APPROXIMATELY 50% OF THE TISSUE INVOLVED BY MALIGNANT TUMOR IN SECTIONS EXAMINED. MALIGNANT TUMOR CELLS PRESENT IN CYTOSPIN PREP. CLICK TO VIEW
SA2398 Sarcoma N/A N/A CLICK TO VIEW
SA2466 Sarcoma Rhabdomyosarcoma NA CLICK TO VIEW
SA3224 Sarcoma NA Malignant tumor, consider as metastatic sarcomatoid carcinoma or carcinosarcoma. CLICK TO VIEW
SA3283 Sarcoma NA sarcoma CLICK TO VIEW
SA3296 Sarcoma NA Right breast: Mesenchymal malignant tumor CLICK TO VIEW
SA3302 Sarcoma NA Left thigh: pleomorphic sarcoma, high-grade, accord with dedifferentiated liposarcoma on the base of medical history. CLICK TO VIEW
SA3829 Sarcoma Ewing?s sarcoma Pelvis: malignant tumor with massive necrosis and invaded bone, cartilage and skeletal muscle, consider Ewing's sarcoma based on medical history and IHC results. Vim+, CD99+, NSE+, CD57 sporadic +, Syn-, CHG-, S-100-, NF-. CK-. Ki67+70% CLICK TO VIEW
SA3831 Sarcoma osteosarcoma Right thigh tumor: spindle cell sarcoma, consider fibrous cellular osteosarcoma on basis of medical history CLICK TO VIEW
SA3839 Sarcoma leiomysarcoma Left pelvis: leiomysarcoma with high malignancy, infiltrating to fat and striated mscle tissues. CLICK TO VIEW
SA3840 Sarcoma osteosarcoma Left proximal tibia: common type of osteosarcoma with chondroblastoma component infiltrating to soft tissue. CLICK TO VIEW
SA3841 Sarcoma NA Puncture sample of scalp tumor: malignant tumor, consider metastatic osteosarcoma based on medical history and IHC results. IHC results: Vim(+), P53(-), S-100(-), CAM5.2(-), CD99(+), EMA(-), CK(-). CLICK TO VIEW
SA3847 Sarcoma Osteosarcoma NA CLICK TO VIEW
SA3849 Sarcoma osteosarcoma Right proximal humerus: common type of osteosarcoma after chemotherapy CLICK TO VIEW
SA3851 Sarcoma osteosarcoma Right femur: common type of osteosarcoma CLICK TO VIEW
SA4008 Sarcoma osteosarcoma Left humerus: osteosarcoma with giant cells component infiltrating to striated muscule. CLICK TO VIEW
SA4013 Sarcoma osteosarcoma Lung: malignant sarcoma, consider metastatic osteosarcoma to lung on basis of medical history. CLICK TO VIEW
SA4028 Sarcoma NA NA CLICK TO VIEW
SA4033 Sarcoma leiomyosarcoma Right thigh: leiomyosarcoma with chondrosarcoma-like and osteosarcoma-like components (malignant mesenchymoma) CLICK TO VIEW
SA4040 Sarcoma NA NA CLICK TO VIEW
SA4058 Sarcoma synovial sarcoma Synovial sarcoma CLICK TO VIEW
SA4060 Sarcoma Osteosarcoma N/A CLICK TO VIEW
SA4061 Sarcoma osteosarcoma Left femur: high grade osteosarcoma, accord with postradiation osteosarcoma based on medical history. CLICK TO VIEW
SA4062 Sarcoma osteosarcoma Osteosarcoma, metastases to lung (collected from lung) CLICK TO VIEW
SA4078 Sarcoma osteosarcoma Left femur: convention osteosarcoma, infiltratiing to surrounding soft tissues. CLICK TO VIEW
SA4091 Sarcoma NA Right fibula: spindle cell sarcoma with high grade component CLICK TO VIEW
SA4094 Sarcoma osteosarcoma Lumbar vertebra: malignant carcinoma, consider small cell osteosarcoma with necrosis, infiltrating adjacent soft tissue. CLICK TO VIEW
SA4098 Sarcoma synovial sarcoma Inferior lobe of right lung: sarcoma, consider metastatic synovial sarcoma based on medical histoty. CLICK TO VIEW
SA4109 Sarcoma chondrosarcoma Left leg: accorded with chondrosarcoma based on morphology and IHC results. CLICK TO VIEW
SA4113 Sarcoma Chondrosarcoma N/A CLICK TO VIEW
SA4138 Sarcoma Osteosarcoma NA CLICK TO VIEW
SA4144 Sarcoma Sarcoma NA CLICK TO VIEW
SA4148 Sarcoma Left pelvis: consider osteocarcinoma recurrence, based on medical history. CLICK TO VIEW
SA4153 Sarcoma Spindle cell sarcoma N/A CLICK TO VIEW
SA4196 Sarcoma synovial sarcoma NA CLICK TO VIEW
SA4197 Sarcoma synovial sarcoma NA CLICK TO VIEW
SA4227 Sarcoma Osteosarcoma N/A CLICK TO VIEW
SA4235 Sarcoma Spindle cell sarcoma N/A CLICK TO VIEW
SA5395 Sarcoma NA NA for clinical diagnosis info. CLICK TO VIEW
SA5396 Sarcoma leiomyoma sarcoma Uterine Leiomyoma sarcoma, Metastatic CLICK TO VIEW

Sorry, no posts matched your criteria.

Create Account to View All Model Data

Already Registered? Login